Book contents
- Rare Causes of Stroke
- Rare Causes of Stroke
- Copyright page
- Contents
- Contributors
- Preface
- 1 Inflammatory Conditions
- 2 Infectious and Postinfectious Vasculitis
- 3 Hypercoagulable Causes of Stroke
- 4 Drug-Related Stroke
- 5 Hereditary and Genetic Causes of Stroke
- 6 Rare Causes of Cardioembolism
- 7 Vasospastic Conditions and Other Vasculopathies
- 8 Other Non-inflammatory Vasculopathies
- 9 Venous Occlusive Conditions
- 10 Bone Disorders and Stroke
- Index
- References
4 - Drug-Related Stroke
Published online by Cambridge University Press: 06 October 2022
Edited by
Book contents
- Rare Causes of Stroke
- Rare Causes of Stroke
- Copyright page
- Contents
- Contributors
- Preface
- 1 Inflammatory Conditions
- 2 Infectious and Postinfectious Vasculitis
- 3 Hypercoagulable Causes of Stroke
- 4 Drug-Related Stroke
- 5 Hereditary and Genetic Causes of Stroke
- 6 Rare Causes of Cardioembolism
- 7 Vasospastic Conditions and Other Vasculopathies
- 8 Other Non-inflammatory Vasculopathies
- 9 Venous Occlusive Conditions
- 10 Bone Disorders and Stroke
- Index
- References
- Type
- Chapter
- Information
- Rare Causes of StrokeA Handbook, pp. 185 - 198Publisher: Cambridge University PressPrint publication year: 2022
References
References
Bushnell, C, McCullough, LD, Awad, IA, et al. Guidelines for the prevention of stroke in women: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45: 1545–1588.CrossRefGoogle ScholarPubMed
Renoux, C, Dell’aniello, S, Garbe, E, Suissa, S. Transdermal and oral hormone replacement therapy and the risk of stroke: A nested case-control study. Br Med J. 2010;340: c2519.CrossRefGoogle ScholarPubMed
Lundberg, GP, Wenger, NK. Menopause hormone therapy: What a cardiologist needs to know. Expert analysis. American College of Cardiology. 2019. www.Menopause Hormone Therapy: What a Cardiologist Needs to Know - American College of Cardiology (acc.org) (accessed February 2022).Google Scholar
Loo, SY, Azoulay, L, Nie, R, et al. Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: A cohort study. Am J Med. 2019;132(9): 1069–1077.e4.CrossRefGoogle ScholarPubMed
Varas-Lorenzo, C, Riera-Guardia, N, Calingaert, B, et al. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2011;20(12): 1225–1236.CrossRefGoogle ScholarPubMed
Cooper, C, Chapurlat, R, Al-Daghri, N, et al. Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: What does the literature say? Drugs Aging. 2019;36(Suppl 1): 15–24.CrossRefGoogle ScholarPubMed
Trajkova, S, d’Errico, A, Soffietti, R, Sacerdote, C, Ricceri, F. Use of Antidepressants and Risk of Incident Stroke: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2019;53(3–4): 142–151.CrossRefGoogle ScholarPubMed
Gamble, DT, Clark, AB, Luben, RN, et al. Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population. Int J Epidemiology. 2018;47(2): 625–633.CrossRefGoogle ScholarPubMed
References
Esse, K, Fossati-Bellani, M, Traylor, A, Martin-Schild, S. Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard. Brain Behav. 2011;1(1): 44–54.CrossRefGoogle ScholarPubMed
Tsatsakis, A, Docea, AO, Calina, D, et al. A mechanistic and pathophysiological approach for stroke associated with drugs of abuse. J Clin Med. 2019;8(9): 1295.CrossRefGoogle ScholarPubMed
Sloan, MA. Illicit drug use/abuse and stroke. Handb Clin Neurol. 2009;93: 823–840.CrossRefGoogle ScholarPubMed
Cheng, YC, Ryan, KA, Qadwai, SA, et al. Cocaine use and risk of ischemic stroke in young adults. 2016;47(4): 918–922.Google ScholarPubMed
Fonseca, AC, Ferro, JM. Drug abuse and stroke. Curr Neurol Neurosci Rep. 2013;13(2): 325.CrossRefGoogle ScholarPubMed